Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Surgery Physician in Philadelphia, PA
NPI: 1366466542Primary Practice Location
THOMAS JEFFERSON UNIVERSITY HOSPITAL
900 Walnut St, Philadelphia, PA
Primary Employer
Jefferson University Physicians
jeffersonhealth.org
HQ Phone
Get M.D. Nader's Phone Numberphone_androidMobile
Get M.D. Nader's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
2004 - 2026
PA State Medical License
2024 - 2026
NJ State Medical License
2024 - 2025
KY State Medical License
1998 - 2006
MA State Medical License
1993 - 2005
IL State Medical License
1994 - 2002
MD State Medical License
American Board of Surgery
Surgery
University of Chicago
Fellowship • Complex General Surgical Oncology
1994 - 1997
St Elizabeth's Medical Center
Residency • Surgery
1989 - 1994
Waltham Weston Hospital Medical Center
Internship • Transitional Year
1988 - 1989
Ain Shams University Faculty of Medicine
Medical School
Until 1985
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 46 | 46 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 24 | 28 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 13 | 14 |
| 4 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 12 | 16 |
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.
Authors: Yuuki Ohara, Huaitian Liu, Amanda J Craig, Shouhui Yang, Paloma Moreno, Tiffany H Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Stefan Ambs, S Perwez Hussain, Nader Hanna
Publication Date: 2024-08
Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare.
Authors: Kaloyan A. Bikov, C. Daniel Mullins, Brian S. Seal, Eberechukwu Onukwugha, Nader Hanna
Publication Date: 2015-08
Clinical Results of Cytoreduction and HIPEC for Malignant Peritoneal Mesothelioma
Authors: H. Richard Alexander, Nader Hanna, James F. Pingpank
Publication Date: 2007-01
Lead Sponsor: University of Maryland, Baltimore
Intervention / Treatment: OTHER: Chemotherapy(FOLFIRINOX) + SBRT prior to surgery if applicable, DRUG: -5-FU (Fluorouracil) 2,400 mg/m2 IV over 46-48 hours, DRUG: -Oxaliplatin 85 mg/m2 IV on Day 1, DRUG: -Irinotecan 180 mg/m2 IV on Day 1
Lead Sponsor: Anchiano Therapeutics Israel Ltd.
Intervention / Treatment: BIOLOGICAL: DTA-H19
